Cargando…
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma
Glucose-6-phosphate dehydrogenase (G6PD) participates in glucose metabolism and it acts as the rate-limiting enzyme of the pentose phosphate pathway (PPP). Recently, G6PD dysregulation has been found in a variety of human cancers. Through analyzing published data in The Cancer Genome Atlas (TCGA), o...
Autores principales: | Zhang, Qiao, Yi, Xiaojia, Yang, Zhe, Han, Qiaoqiao, Di, Xuesong, Chen, Fufei, Wang, Yanling, Yi, Zihan, Kuang, Yingmin, Zhu, Yuechun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370510/ https://www.ncbi.nlm.nih.gov/pubmed/28367246 http://dx.doi.org/10.7150/jca.16858 |
Ejemplares similares
-
G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS-MAPK axis pathway
por: Zhang, Qiao, et al.
Publicado: (2020) -
NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
por: Zhang, Qiao, et al.
Publicado: (2020) -
Correction to: NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
por: Zhang, Qiao, et al.
Publicado: (2020) -
G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3
por: Zhang, Qiao, et al.
Publicado: (2017) -
G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression
por: Zhang, Qiao, et al.
Publicado: (2022)